Vitura Health Temettü
Temettü kriter kontrolleri 0/6
Vitura Health does not currently pay a dividend.
Anahtar bilgiler
0%
Temettü verimi
-0.7%
Geri Alım Getirisi
Toplam Hissedar Getirisi | -0.7% |
Gelecekteki Temettü Verimi | 0% |
Temettü Büyümesi | n/a |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | AU$0.010 |
Ödeme oranı | 0% |
Son temettü güncellemeleri
Recent updates
There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise
Oct 17Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?
Oct 13Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture
Sep 07Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings
Aug 12Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Aug 12The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%
Apr 25Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?
Apr 11Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%
Feb 27Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching
Feb 25Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)
Dec 13Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet
Nov 21Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?
Nov 01Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching
Jul 18Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%
Sep 12If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity
Sep 05Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if VIT's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if VIT's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Vitura Health Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (VIT) | 0% |
Pazarın Alt %25'i (AU) | 2.6% |
Pazarın En İyi %25'i (AU) | 6.1% |
Sektör Ortalaması (Pharmaceuticals) | 2.2% |
Analist tahmini (VIT) (3 yıla kadar) | 0% |
Önemli Temettü: Unable to evaluate VIT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate VIT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: VIT is not paying a notable dividend for the Australian market.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as VIT has not reported any payouts.